Back to Authors

Tangalos, Eric G.

A5057698408 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 43

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

Neurology | May 13, 2012 | Volume: 55 | Issue: 4 | Pages: 484-490

10.1212/wnl.55.4.484 | PMID 10953178

Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease

Neurology | May 13, 2012 | Volume: 55 | Issue: 2 | Pages: 210-217

10.1212/wnl.55.2.210 | PMID 10908893

Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease

Neurology | May 13, 2012 | Volume: 51 | Issue: 4 | Pages: 993-999

10.1212/wnl.51.4.993 | PMID 9781519

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

Neurology | May 13, 2012 | Volume: 49 | Issue: 3 | Pages: 786-794

10.1212/wnl.49.3.786 | PMID 9305341

MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease

Neurology | May 13, 2012 | Volume: 42 | Issue: 1 | Pages: 183-183

10.1212/wnl.42.1.183 | PMID 1734300

The incidence of MCI differs by subtype and is higher in men

Neurology | January 26, 2012 | Volume: 78 | Issue: 5 | Pages: 342-351

10.1212/wnl.0b013e3182452862 | PMID 22282647

O4‐05‐04: Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: A population‐based study

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2011.05.2000

Prevalence of mild cognitive impairment is higher in men

Neurology | September 6, 2010 | Volume: 75 | Issue: 10 | Pages: 889-897

10.1212/wnl.0b013e3181f11d85 | PMID 20820000

Association of C‐reactive protein with mild cognitive impairment

Alzheimer's & Dementia | September 13, 2009 | Volume: 5 | Issue: 5 | Pages: 398-405

10.1016/j.jalz.2009.01.025 | PMID 19751919

Background Inflammation is proposed to play a role in the development of Alzheimer's disease, and may also be involved in the pathogenesis of mild cognitive impairment (MCI). This study examined the association of inflammatory markers in serum or plasma with prevalent MCI and MCI subtypes in a population‐based sample. Methods Olmsted County, MN, residents aged 70–89 years on October 1, 2004, were evaluated using the Clinical Dementia Rating Scale, a neurological evaluation, and neuropsychological testing. Information ascertained for each participant was reviewed by an expert panel of neuropsychologists, physicians, and nurses, and a diagnosis of normal cognition, MCI, or dementia was made by consensus. C‐reactive protein (CRP), interleukin‐6 (IL‐6), tumor necrosis alpha (TNFα), and adiponectin were measured at baseline. Results Among 313 subjects with MCI and 1570 cognitively normal subjects, a CRP level in the upper quartile (>3.3 mg/L) was significantly associated with MCI (odds ratio [OR], 1.42; 95% confidence interval [CI], 1.00–2.01) and with nonamnestic MCI (OR, 2.05; 95% CI, 1.12–3.78) after adjusting for age, sex, and years of education. However, there was no association with amnestic MCI (OR, 1.21; 95% CI, 0.81–1.82). No association was observed with the other inflammatory markers. Conclusions Plasma CRP is associated with prevalent MCI and with nonamnestic MCI in elderly, nondemented persons in a population‐based setting. These findings suggest the involvement of inflammation in the pathogenesis of MCI.
P1‐202: APOE and quality of life in the oldest old

Alzheimer's & Dementia | June 25, 2009 | Volume: 5 | Issue: 4S_Part_8 | Pages: No page available

10.1016/j.jalz.2009.04.209